ArticleThe American journal of tropical medicine and hygiene2025
Cytokine Production in Response to Soluble Leishmania Aethiopica Antigen by Whole Blood Cells from Patients with Different Clinical Presentations of Cutaneous Leishmaniasis.
Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From dogma to data: charting a path forward for clinico-immunological research in Ethiopian cutaneous leishmaniasis.Infectious diseases of poverty · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous leishmaniasis (CL), a parasitic disease caused by Leishmania aethiopica, is a major health problem in Ethiopia. It presents mostly as three different clinical forms: localized CL characterized by small lesions that ulcerate; diffuse CL defined by multiple nonulcerating nodules; and mucocutaneous leishmaniasis, where the mucosa of the nose or the mouth is affected. The mechanisms resulting in the development of these different clinical presentation are still poorly understood. Here, we recruited a cohort of CL patients presenting with different forms of CL in northwest Ethiopia as well as cohort of healthy nonendemic controls. We assessed the capacity of whole blood cells from these cohorts to produce cytokines in response to soluble L. aethiopica antigen and compared these levels between the different clinical presentations of CL and healthy nonendemic controls. Our results show that the levels of antigen-specific cytokines produced by whole blood cells from CL patients were higher as compared with controls. However, these cytokine levels were similar among the different clinical presentations. In conclusion, the results of our study indicate that variations in clinical manifestations of CL are not associated with differences in antigen-specific cytokine profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.